VCM
TMO icon

Vigilant Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Vigilant Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$145K Hold
277
– – 0.01% 178
2023
Q1 		$160K Sell
277
-159
-36% -$89.6K 0.01% 159
2022
Q4 		$240K Sell
436
-668
-61% -$354K 0.02% 133
2022
Q3 		$560K Buy
1,104
+6
+0.5% +$3.36K 0.05% 80
2022
Q2 		$597K Buy
1,098
+24
+2% +$13.2K 0.05% 78
2022
Q1 		$634K Hold
1,074
– – 0.05% 87
2021
Q4 		$717K Hold
1,074
– – 0.05% 83
2021
Q3 		$614K Buy
1,074
+145
+16% +$79.6K 0.05% 77
2021
Q2 		$469K Buy
929
+2
+0.2% +$944 0.04% 90
2021
Q1 		$423K Sell
927
-427
-32% -$204K 0.04% 89
2020
Q4 		$631K Sell
1,354
-275
-17% -$129K 0.06% 66
2020
Q3 		$719K Buy
1,629
+275
+20% +$114K 0.08% 62
2020
Q2 		$491K Buy
1,354
+630
+87% +$211K 0.06% 68
2020
Q1 		$205K Buy
724
+445
+159% +$140K 0.03% 108
2019
Q4 		$91K Hold
279
– – 0.01% 213
2019
Q3 		$81K Sell
279
-6
-2% -$1.72K 0.01% 214
2019
Q2 		$84K Buy
285
+6
+2% +$1.65K 0.01% 197
2019
Q1 		$76K Sell
279
-100
-26% -$24.9K 0.01% 200
2018
Q4 		$85K Sell
379
-25
-6% -$5.87K 0.01% 198
2018
Q3 		$99K Buy
404
+34
+9% +$7.82K 0.01% 203
2018
Q2 		$77K Sell
370
-272
-42% -$57.7K 0.01% 205
2018
Q1 		$133K Buy
642
+354
+123% +$74.3K 0.02% 150
2017
Q4 		$55K Buy
288
+43
+18% +$8.24K 0.01% 212
2017
Q3 		$46K Hold
245
– – 0.01% 183
2017
Q2 		$43K Hold
245
– – 0.01% 172
2017
Q1 		$38K Hold
245
– – 0.01% 180
2016
Q4 		$35K Sell
245
-68
-22% -$10K 0.01% 179
2016
Q3 		$50K Buy
313
+170
+119% +$26.2K 0.01% 172
2016
Q2 		$21K Buy
+143
New +$21.1K ﹤0.01% 225

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Vigilant Capital Management's TMO Position: Q2 2023 in Review

Vigilant Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2023 at 277 shares worth $145K. The position accounts for 0.01% of the portfolio, ranked #178.

Vigilant Capital Management first reported a position in TMO in Q2 2016 and has held it in 29 quarters since. The position peaked at $719K in Q3 2020. 2,387 funds tracked by Wall St. Rank hold TMO as of Q2 2023.

  • Vigilant Capital Management held 277 shares of Thermo Fisher Scientific worth $145K as of Q2 2023.
  • Vigilant Capital Management left its Thermo Fisher Scientific share count unchanged in Q2 2023.
  • Thermo Fisher Scientific made up 0.01% of Vigilant Capital Management's portfolio in Q2 2023, its #178 holding.
  • Vigilant Capital Management first reported a position in Thermo Fisher Scientific in Q2 2016 and has held it in 29 quarters since.
  • Vigilant Capital Management's Thermo Fisher Scientific position peaked at $719K in Q3 2020.
  • 2,387 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2023.

Based on Vigilant Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.